![Sebastien Hazard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Dr. Sebastien Hazard was previously employed as a Chief Medical Officer & Executive Vice President by Imunon, Inc., a Senior VP & Head-Clinical Development by Bicycle Therapeutics Plc, a Head-Clinical Development by GlaxoSmithKline Plc, and a Senior Medical Director-Clinical Development by Tesaro, Inc. He received his MBA from INSEAD.
Eerdere bekende functies van Sebastien Hazard
| Bedrijven | Functie | Einde |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 01-09-2023 |
| GSK PLC | Hoofd Techniek/Wetenschap/O&O | 01-04-2021 |
| TESARO INC | Hoofd Techniek/Wetenschap/O&O | 01-05-2019 |
| IMUNON, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Sebastien Hazard
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
65
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bicycle Therapeutics Plc
 Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
